반려동물용 보충제 시장 규모, 점유율, 성장률 및 세계 업계 분석 : 유형 및 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of pet supplements Market

The global pet supplements market is witnessing steady expansion, driven by rising pet humanization, preventive healthcare awareness, and increasing disposable income. According to industry analysis, the market was valued at USD 2.95 billion in 2025 and is projected to grow to USD 3.14 billion in 2026. Further, the market is expected to reach USD 4.82 billion by 2034, registering a CAGR of 6.34% during 2026-2034.

North America dominated the global market in 2025, accounting for 43.37% market share, supported by strong pet ownership rates and premiumization trends.

Market Overview

Pet supplements include concentrated health-enhancing ingredients such as glucosamine, probiotics, prebiotics, multivitamins, fatty acids, and herbal extracts. These products are available in tablets, capsules, chewables, powders, and liquid forms and are primarily formulated for skin & coat health, hip & joint support, digestive health, and overall wellness.

The increasing trend of treating pets as family members has significantly influenced purchasing behavior. Growing awareness of breed-specific nutrition and age-related health conditions has further strengthened product demand.

Market Drivers

1. Growing Demand Among Millennial Pet Owners

Millennials represent a substantial portion of global pet owners and are more inclined toward preventive healthcare and personalized nutrition solutions. Digital awareness, e-commerce familiarity, and increased spending capacity have accelerated supplement adoption.

2. Increasing Global Pet Ownership

Pet adoption rates continue to rise globally, especially in Asia Pacific and Latin America. Rising disposable income and lifestyle changes have encouraged spending on pet health products. Preventive veterinary care and aging pet populations further drive supplement consumption.

Market Restraints

Stringent Regulatory Framework

Pet supplements are highly regulated in developed markets such as the U.S. and Europe. Regulatory differences across countries, labeling requirements, and classification ambiguities (treat vs supplement vs functional food) create compliance challenges. These factors may hinder smooth international expansion.

Market Opportunities

E-commerce and Subscription-Based Models

Online distribution channels are expanding rapidly. Direct-to-consumer platforms and subscription models provide recurring revenue streams and improved customer engagement. Digital platforms enable personalized recommendations, boosting customer loyalty and repeat purchases.

Market Trends

Rising Demand for Personalized Supplements

Consumers increasingly seek customized solutions targeting anxiety, immunity, cognitive support, digestive balance, and mobility enhancement. Natural, organic, and CBD-based formulations are gaining traction.

Segmentation Analysis

By Pet Type

• Dogs hold the largest share (49.55% in 2026) due to higher adoption rates and preventive care needs.
• Cats represent the second-largest segment.
• Other pets contribute moderately.

By Form

• Chewables dominated with 43.84% share in 2026 due to convenience and palatability.
• Tablets & capsules hold the second position.
• Liquids & powders show moderate growth.

By Function

• Hip & joint supplements accounted for 40.24% share in 2026, driven by aging pets and joint issues.
• Digestive health supplements show strong growth.
• Skin & coat and other functions contribute steadily.

By Supplement Type

• Glucosamine leads with 37.24% share in 2026 due to joint health benefits.
• Probiotics & prebiotics are the fastest-growing segment.
• Multivitamins and resveratrol maintain stable demand.

By Distribution Channel

• Offline retail leads the market due to product availability and brand visibility.
• Online channels are witnessing the fastest growth due to digital expansion.

Regional Outlook

North America

Valued at USD 1.36 billion in 2025, rising to USD 1.44 billion in 2026, North America remains the largest regional market. The U.S. drives growth through premium and natural product demand.

Europe

Strong pet humanization and sustainability awareness support steady growth. The U.K. and Germany are key contributors.

Asia Pacific

Expected to register the highest growth rate. Rising pet adoption in China, India, Japan, and Australia fuels expansion. Japan's growing pet population supports steady supplement demand.

South America

Urbanization and changing lifestyles in Brazil and Argentina are boosting market penetration.

Middle East & Africa

Growing middle-class income, premium product adoption, and e-commerce expansion support market growth.

Competitive Landscape

The market is moderately consolidated. Leading companies focus on mergers, acquisitions, product innovation, and geographic expansion.

Key Players:

1. Nestle S.A.

2. Mars, Incorporated

3. H&H Group

4. Virbac Corporation

5. General Mills Inc.

Companies are expanding portfolios with soft chews, weight management bites, probiotic blends, and joint health formulations.

Impact of Tariffs (2025)

The U.S. reciprocal tariffs introduced in April 2025 disrupted supply chains, particularly for imported raw materials. Industry associations collaborated to mitigate cost pressures and maintain supply stability. Short-term pricing fluctuations may affect growth momentum.

Conclusion

The global pet supplements market demonstrates consistent expansion, growing from USD 2.95 billion in 2025 to USD 3.14 billion in 2026, and projected to reach USD 4.82 billion by 2034 at a CAGR of 6.34%. Rising pet humanization, preventive healthcare adoption, personalized nutrition trends, and e-commerce expansion will continue to drive long-term growth. North America leads the market, while Asia Pacific is expected to witness the fastest expansion during the forecast period.

Segmentations By Pet Type, Form, Function, Supplement Type, Distribution Channel, and Region

Segmentation By Pet Type

• Dog
• Cat
• Others

By Form

• Tablets & Capsules
• Chewable
• Liquid & Powder

By Function

• Skin & Coat
• Hip & Joint
• Digestive Health
• Others

By Supplement Type

• Glucosamine
• Probiotics & Prebiotics
• Multivitamins
• Resveratrol
• Others

By Distribution Channel

• Online
• Offline

By Region

• North America (By Pet Type, Form, Function, Supplement Type, Distribution Channel, and Country)
• U.S. (By Supplement Type)
• Canada (By Supplement Type)
• Mexico (By Supplement Type)
• Europe (By Pet Type, Form, Function, Supplement Type, Distribution Channel, and Country)
• France (By Supplement Type)
• Germany (By Supplement Type)
• Italy (By Supplement Type)
• Spain (By Supplement Type)
• U.K. (By supplement Type)
• Rest of Europe (By Supplement Type)
• Asia Pacific (By Pet Type, Form, Function, Supplement Type, Distribution Channel, and Country)
• Australia (By Supplement Type)
• China (By Supplement Type)
• India (By Supplement Type)
• Japan (By Supplement Type)
• Rest of Asia Pacific (By Supplement Type)
• South America (By Pet Type, Form, Function, Supplement Type, Distribution Channel, and Country)
• Argentina (By Supplement Type)
• Brazil (By Supplement Type)
• Rest of South America (By Supplement Type)
• Middle East and Africa (By Pet Type, Form, Function, Supplement Type, Distribution Channel, and Country)
• South Africa (By Supplement Type)
• UAE (By Supplement Type)
• Rest of the Middle East & Africa (By Supplement Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends
• 3.5. Impact of Tariffs

4. Key Insights

• 4.1. Market Overview of Related/Parent Market
• 4.2. Industry SWOT Analysis
• 4.3. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches
• 4.4. Supply Chain Analysis
• 4.5. Market Analysis and Insights (in Relation to U.S. Tariff)

5. Global Pet Supplements Market Analysis, Insights and Forecast, 2025-2034

• 5.1. Key Findings / Summary
• 5.2. Market Size Estimates and Forecast
  • 5.2.1. By Pet Type
    • 5.2.1.1. Dogs
    • 5.2.1.2. Cats
    • 5.2.1.3. Others
  • 5.2.2. By Form
    • 5.2.2.1. Tablets & Capsules
    • 5.2.2.2. Chewable
    • 5.2.2.3. Liquid & Powder
  • 5.2.3. By Function
    • 5.2.3.1. Skin & Coat
    • 5.2.3.2. Hip & Joint
    • 5.2.3.3. Digestive Health
    • 5.2.3.4. Others
  • 5.2.4. By Supplement Type
    • 5.2.4.1. Glucosamine
    • 5.2.4.2. Probiotics & Prebiotics
    • 5.2.4.3. Multivitamins
    • 5.2.4.4. Resveratrol
    • 5.2.4.5. Others
  • 5.2.5. By Distribution Channel
    • 5.2.5.1. Online
    • 5.2.5.2. Offline
  • 5.2.6. By Region (Value)
    • 5.2.6.1. North America
    • 5.2.6.2. Europe
    • 5.2.6.3. Asia Pacific
    • 5.2.6.4. South America
    • 5.2.6.5. Middle East and Africa

6. North America Pet Supplements Market Analysis, Insights and Forecast, 2025-2034

• 6.1. Key Findings / Summary
• 6.2. Market Size Estimates and Forecast
  • 6.2.1. By Pet Type
    • 6.2.1.1. Dogs
    • 6.2.1.2. Cats
    • 6.2.1.3. Others
  • 6.2.2. By Form
    • 6.2.2.1. Tablets & Capsules
    • 6.2.2.2. Chewable
    • 6.2.2.3. Liquid & Powder
  • 6.2.3. By Function
    • 6.2.3.1. Skin & Coat
    • 6.2.3.2. Hip & Joint
    • 6.2.3.3. Digestive Health
    • 6.2.3.4. Others
  • 6.2.4. By Supplement Type
    • 6.2.4.1. Glucosamine
    • 6.2.4.2. Probiotics & Prebiotics
    • 6.2.4.3. Multivitamins
    • 6.2.4.4. Resveratrol
    • 6.2.4.5. Others
  • 6.2.5. By Distribution Channel
    • 6.2.5.1. Online
    • 6.2.5.2. Offline
  • 6.2.6. By Country
    • 6.2.6.1. U.S.
      • 6.2.6.1.1. By Supplement Type
        • 6.2.6.1.1.1. Glucosamine
        • 6.2.6.1.1.2. Probiotics & Prebiotics
        • 6.2.6.1.1.3. Multivitamins
        • 6.2.6.1.1.4. Resveratrol
        • 6.2.6.1.1.5. Others
    • 6.2.6.2. Canada
      • 6.2.6.2.1. By Supplement Type
        • 6.2.6.2.1.1. Glucosamine
        • 6.2.6.2.1.2. Probiotics & Prebiotics
        • 6.2.6.2.1.3. Multivitamins
        • 6.2.6.2.1.4. Resveratrol
        • 6.2.6.2.1.5. Others
    • 6.2.6.3. Mexico
      • 6.2.6.3.1. By Supplement Type
        • 6.2.6.3.1.1. Glucosamine
        • 6.2.6.3.1.2. Probiotics & Prebiotics
        • 6.2.6.3.1.3. Multivitamins
        • 6.2.6.3.1.4. Resveratrol
        • 6.2.6.3.1.5. Others

7. Europe Pet Supplements Market Analysis, Insights and Forecast, 2025-2034

• 7.1. Key Findings / Summary
• 7.2. Market Size Estimates and Forecast
  • 7.2.1. By Pet Type
    • 7.2.1.1. Dogs
    • 7.2.1.2. Cats
    • 7.2.1.3. Others
  • 7.2.2. By Form
    • 7.2.2.1. Tablets & Capsules
    • 7.2.2.2. Chewable
    • 7.2.2.3. Liquid & Powder
  • 7.2.3. By Function
    • 7.2.3.1. Skin & Coat
    • 7.2.3.2. Hip & Joint
    • 7.2.3.3. Digestive Health
    • 7.2.3.4. Others
  • 7.2.4. By Supplement Type
    • 7.2.4.1. Glucosamine
    • 7.2.4.2. Probiotics & Prebiotics
    • 7.2.4.3. Multivitamins
    • 7.2.4.4. Resveratrol
    • 7.2.4.5. Others
  • 7.2.5. By Distribution Channel
    • 7.2.5.1. Online
    • 7.2.5.2. Offline
  • 7.2.6. By Country
    • 7.2.6.1. France
      • 7.2.6.1.1. By Supplement Type
        • 7.2.6.1.1.1. Glucosamine
        • 7.2.6.1.1.2. Probiotics & Prebiotics
        • 7.2.6.1.1.3. Multivitamins
        • 7.2.6.1.1.4. Resveratrol
        • 7.2.6.1.1.5. Others
    • 7.2.6.2. Germany
      • 7.2.6.2.1. By Supplement Type
        • 7.2.6.2.1.1. Glucosamine
        • 7.2.6.2.1.2. Probiotics & Prebiotics
        • 7.2.6.2.1.3. Multivitamins
        • 7.2.6.2.1.4. Resveratrol
        • 7.2.6.2.1.5. Others
    • 7.2.6.3. Italy
      • 7.2.6.3.1. By Supplement Type
        • 7.2.6.3.1.1. Glucosamine
        • 7.2.6.3.1.2. Probiotics & Prebiotics
        • 7.2.6.3.1.3. Multivitamins
        • 7.2.6.3.1.4. Resveratrol
        • 7.2.6.3.1.5. Others
    • 7.2.6.4. Spain
      • 7.2.6.4.1. By Supplement Type
        • 7.2.6.4.1.1. Glucosamine
        • 7.2.6.4.1.2. Probiotics & Prebiotics
        • 7.2.6.4.1.3. Multivitamins
        • 7.2.6.4.1.4. Resveratrol
        • 7.2.6.4.1.5. Others
    • 7.2.6.5. U.K.
      • 7.2.6.5.1. By Supplement Type
        • 7.2.6.5.1.1. Glucosamine
        • 7.2.6.5.1.2. Probiotics & Prebiotics
        • 7.2.6.5.1.3. Multivitamins
        • 7.2.6.5.1.4. Resveratrol
        • 7.2.6.5.1.5. Others
    • 7.2.6.6. Rest of Europe
      • 7.2.6.6.1. By Supplement Type
        • 7.2.6.6.1.1. Glucosamine
        • 7.2.6.6.1.2. Probiotics & Prebiotics
        • 7.2.6.6.1.3. Multivitamins
        • 7.2.6.6.1.4. Resveratrol
        • 7.2.6.6.1.5. Others

8. Asia Pacific Pet Supplements Market Analysis, Insights and Forecast, 2025-2034

• 8.1. Key Findings / Summary
  • 8.1.1. By Pet Type
    • 8.1.1.1. Dogs
    • 8.1.1.2. Cats
    • 8.1.1.3. Others
  • 8.1.2. By Form
    • 8.1.2.1. Tablets & Capsules
    • 8.1.2.2. Chewable
    • 8.1.2.3. Liquid & Powder
  • 8.1.3. By Function
    • 8.1.3.1. Skin & Coat
    • 8.1.3.2. Hip & Joint
    • 8.1.3.3. Digestive Health
    • 8.1.3.4. Others
  • 8.1.4. By Supplement Type
    • 8.1.4.1. Glucosamine
    • 8.1.4.2. Probiotics & Prebiotics
    • 8.1.4.3. Multivitamins
    • 8.1.4.4. Resveratrol
    • 8.1.4.5. Others
  • 8.1.5. By Distribution Channel
    • 8.1.5.1. Online
    • 8.1.5.2. Offline
  • 8.1.6. By Country
    • 8.1.6.1. Australia
      • 8.1.6.1.1. By Supplement Type
        • 8.1.6.1.1.1. Glucosamine
        • 8.1.6.1.1.2. Probiotics & Prebiotics
        • 8.1.6.1.1.3. Multivitamins
        • 8.1.6.1.1.4. Resveratrol
        • 8.1.6.1.1.5. Others
    • 8.1.6.2. China
      • 8.1.6.2.1. By Supplement Type
        • 8.1.6.2.1.1. Glucosamine
        • 8.1.6.2.1.2. Probiotics & Prebiotics
        • 8.1.6.2.1.3. Multivitamins
        • 8.1.6.2.1.4. Resveratrol
        • 8.1.6.2.1.5. Others
    • 8.1.6.3. India
      • 8.1.6.3.1. By Supplement Type
        • 8.1.6.3.1.1. Glucosamine
        • 8.1.6.3.1.2. Probiotics & Prebiotics
        • 8.1.6.3.1.3. Multivitamins
        • 8.1.6.3.1.4. Resveratrol
        • 8.1.6.3.1.5. Others
    • 8.1.6.4. Japan
      • 8.1.6.4.1. By Supplement Type
        • 8.1.6.4.1.1. Glucosamine
        • 8.1.6.4.1.2. Probiotics & Prebiotics
        • 8.1.6.4.1.3. Multivitamins
        • 8.1.6.4.1.4. Resveratrol
        • 8.1.6.4.1.5. Others
    • 8.1.6.5. Rest of Asia Pacific
      • 8.1.6.5.1. By Supplement Type
        • 8.1.6.5.1.1. Glucosamine
        • 8.1.6.5.1.2. Probiotics & Prebiotics
        • 8.1.6.5.1.3. Multivitamins
        • 8.1.6.5.1.4. Resveratrol
        • 8.1.6.5.1.5. Others

9. South America Pet Supplements Market Analysis, Insights and Forecast, 2025-2034

• 9.1. Key Findings / Summary
  • 9.1.1. By Pet Type
    • 9.1.1.1. Dogs
    • 9.1.1.2. Cats
    • 9.1.1.3. Others
  • 9.1.2. By Form
    • 9.1.2.1. Tablets & Capsules
    • 9.1.2.2. Chewable
    • 9.1.2.3. Liquid & Powder
  • 9.1.3. By Function
    • 9.1.3.1. Skin & Coat
    • 9.1.3.2. Hip & Joint
    • 9.1.3.3. Digestive Health
    • 9.1.3.4. Others
  • 9.1.4. By Supplement Type
    • 9.1.4.1. Glucosamine
    • 9.1.4.2. Probiotics & Prebiotics
    • 9.1.4.3. Multivitamins
    • 9.1.4.4. Resveratrol
    • 9.1.4.5. Others
  • 9.1.5. By Distribution Channel
    • 9.1.5.1. Online
    • 9.1.5.2. Offline
  • 9.1.6. By Country
    • 9.1.6.1. Argentina
      • 9.1.6.1.1. By Supplement Type
        • 9.1.6.1.1.1. Glucosamine
        • 9.1.6.1.1.2. Probiotics & Prebiotics
        • 9.1.6.1.1.3. Multivitamins
        • 9.1.6.1.1.4. Resveratrol
        • 9.1.6.1.1.5. Others
    • 9.1.6.2. Brazil
      • 9.1.6.2.1. By Supplement Type
        • 9.1.6.2.1.1. Glucosamine
        • 9.1.6.2.1.2. Probiotics & Prebiotics
        • 9.1.6.2.1.3. Multivitamins
        • 9.1.6.2.1.4. Resveratrol
        • 9.1.6.2.1.5. Others
    • 9.1.6.3. Rest of South America
      • 9.1.6.3.1. By Supplement Type
        • 9.1.6.3.1.1. Glucosamine
        • 9.1.6.3.1.2. Probiotics & Prebiotics
        • 9.1.6.3.1.3. Multivitamins
        • 9.1.6.3.1.4. Resveratrol
        • 9.1.6.3.1.5. Others

10. Middle East & Africa Pet Supplements Market Analysis, Insights and Forecast, 2025-2034

• 10.1. Key Findings / Summary
  • 10.1.1. By Pet Type
    • 10.1.1.1. Dogs
    • 10.1.1.2. Cats
    • 10.1.1.3. Others
  • 10.1.2. By Form
    • 10.1.2.1. Tablets & Capsules
    • 10.1.2.2. Chewable
    • 10.1.2.3. Liquid & Powder
  • 10.1.3. By Function
    • 10.1.3.1. Skin & Coat
    • 10.1.3.2. Hip & Joint
    • 10.1.3.3. Digestive Health
    • 10.1.3.4. Others
  • 10.1.4. By Supplement Type
    • 10.1.4.1. Glucosamine
    • 10.1.4.2. Probiotics & Prebiotics
    • 10.1.4.3. Multivitamins
    • 10.1.4.4. Resveratrol
    • 10.1.4.5. Others
  • 10.1.5. By Distribution Channel
    • 10.1.5.1. Online
    • 10.1.5.2. Offline
  • 10.1.6. By Country
    • 10.1.6.1. South Africa
      • 10.1.6.1.1. By Supplement Type
        • 10.1.6.1.1.1. Glucosamine
        • 10.1.6.1.1.2. Probiotics & Prebiotics
        • 10.1.6.1.1.3. Multivitamins
        • 10.1.6.1.1.4. Resveratrol
        • 10.1.6.1.1.5. Others
    • 10.1.6.2. UAE
      • 10.1.6.2.1. By Supplement Type
        • 10.1.6.2.1.1. Glucosamine
        • 10.1.6.2.1.2. Probiotics & Prebiotics
        • 10.1.6.2.1.3. Multivitamins
        • 10.1.6.2.1.4. Resveratrol
        • 10.1.6.2.1.5. Others
    • 10.1.6.3. Rest of Middle East & Africa
      • 10.1.6.3.1. By Supplement Type
        • 10.1.6.3.1.1. Glucosamine
        • 10.1.6.3.1.2. Probiotics & Prebiotics
        • 10.1.6.3.1.3. Multivitamins
        • 10.1.6.3.1.4. Resveratrol
        • 10.1.6.3.1.5. Others

11. Competitive Matrix

• 11.1. Business Strategies Adopted By Leading Players
• 11.2. Global Pet Supplements Market Revenue Share/Ranking Analysis, By Key Manufacturers, 2025

12. Company Profiles

• 12.1. FoodScience LLC
  • 12.1.1. Overview
  • 12.1.2. Description
  • 12.1.3. Product Portfolio
  • 12.1.4. Financials (Data as available in the public domain and/or on paid databases)
  • 12.1.5. Recent Developments
• 12.2. General Mills Inc.
• 12.3. General Nutrition Centers, Inc.
• 12.4. H&H Group
• 12.5. Mars, Incorporated
• 12.6. Nestle S.A.
• 12.7. Nutramax Laboratories, Inc.
• 12.8. PetLab Co.
• 12.9. Virbac Corporation
• 12.10. Vitapower Limited

13. Strategic Recommendations